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Various degrees of neural reorganization may occur in affected and unaffected
hemispheres in the early phase after stroke and several months later. Recent literature
suggests to apply a stratification based on lesion location and to consider patients with
cortico-subcortical and subcortical strokes separately: different lesion location may also
influence therapeutic response. In this study we used a longitudinal approach to perform
TMS assessment (Motor Evoked Potentials, MEP, and Silent Period, SP) and clinical
evaluations (Barthel Index, Fugl-Meyer Assessment for upper limb motor function and
Wolf Motor Function Test) in 10 cortical-subcortical and 10 subcortical ischemic stroke
patients. Evaluations were performed in a window between 10 and 45 days (t0) and at 3
months after the acute event (t1). Our main finding is that 3 months after the acute event
patients affected by subcortical stroke presented a reduction in contralateral SP duration
in the unaffected hemisphere; this trend is related to clinical improvement of upper limb
motor function. In conclusion, SP proved to be a valid parameter to characterize cortical
reorganization patterns in stroke survivors and provided useful information about motor
recovery within 3 months in subcortical patients.
Keywords: stroke, functional recovery, cortical excitability, motor evoked potentials, silent period, intracortical
inhibition, unaffected hemisphere, clinical neurophysiology
INTRODUCTION
New frontiers in stroke rehabilitation aim to improve functional recovery taking advantage
from the knowledge of mechanisms of cortical reorganization that occur after the acute event
(Schaechter, 2004), the so-called “top-down” approach (Chisari, 2015). Literature findings have
provided insight into the mechanisms of behavioral rehabilitation techniques, such as constraint-
induced movement therapy (Liepert, 2006), and have led to the development of cortical stimulation
protocols to improve upper limb recovery (Ward andCohen, 2004; Nowak et al., 2008; Chisari et al.,
2014). The main hypothesis is that an imbalanced inter-hemispheric inhibition occurs following
stroke, so the purpose of various rehabilitation approaches is to increase excitability of perilesional
intact regions of the affected hemisphere and/or to decrease excitability of the contralesional
hemisphere (Hummel and Cohen, 2006; Nowak et al., 2009). Anyway, until now still no customized
treatment has been proposed strictly based on the correlations between neurophysiological and
functional evaluations.
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Transcranial magnetic stimulation (TMS) is a valid tool to
obtain data about cortical reorganization (Rossini et al., 2003).
TMS is currently used to elicit motor evoked potential (MEP),
recorded by surface electromyography (EMG). MEP presence, as
a measure of cortical excitability changes and corticospinal tract
integrity, offers useful prognostic information about functional
outcome (Hendricks et al., 2002; Brouwer and Schryburt-Brown,
2006; Pizzi et al., 2009; Stinear et al., 2014). In pre-activated
muscles, TMS may also induce a transient suppression of
the EMG-activity after MEP, the so-called silent period (SP)
(Kukowski and Haug, 1991; Uozumi et al., 1992), as an inhibitory
effect. SP is reported to be abnormally increased in the paretic
hand after a stroke (Haug and Kukowski, 1994; Braune and Fritz,
1996; Harris-Love et al., 2016) and tend to decrease with motor
recovery. To date, studies on the role of the SP in predicting
motor recovery after severe stroke showed rather inconsistent
results (van Kuijk et al., 2005, 2014).
Starting from the study conducted by Liepert et al. (2005)
the impact of lesion location on motor excitability and
motor performance was investigated. The authors evaluated
patients with pure motor strokes in four different brain areas
(motor cortex lesions, striatocapsular lesions, lacunar lesions
of the internal capsule and paramedian pontine lesions),
concluding that lesion location determines a specific pattern of
motor excitability changes. Recently Thickbroom et al. (2015)
highlighted that both the anatomical level of the lesion and
to the degree of paretic motor impairment are related cortical
excitability and reorganization after stroke. These findings
suggest that rehabilitative trials should stratify patients basing on
lesion type.
Coupar et al. (2011) also suggest that integrating early clinical
data with neurophysiological measurements could be useful to
predict long-term recovery and outcome. A remarkable example
is the study conducted by Di Lazzaro et al. (2010), which
evaluated whether long-term potentiation (LTP)- and long-term
depression (LTD)-like changes produced by intermittent theta
burst stimulation (iTBS) in acute stroke correlate with outcome
at 6 months. They recruited ischemic stroke patients (both
with cortical and subcortical lesions) in the first 10 days after
stroke, finding that functional recovery is directly correlated with
LTP-like changes in affected hemisphere (AH) and LTD-like
changes in unaffected hemisphere (UH) and inversely correlated
with the baseline excitability of UH. Nevertheless, it is suitable
to underline that neurophysiological data during early period
post-stroke may suffer from wide inter-subject variability. In
particular, Swayne et al. (2008) found that day-to-day variation
in clinical performance was unrelated to physiological measures
in the first days after the acute event.
Following these considerations our hypothesis was that
different stroke lesion location may imply differences in the
mechanisms of brain reorganization that lead motor recovery
in subacute phase. Our aim was to identify neurophysiological
parameters that can be used as markers to describe motor
recovery and as factors to guide neurorehabilitation treatment in
subacute stroke patients with different lesions.
For this reason we correlated neurophysiological and
functional features in a cohort of stroke patients recruited in a
specific time window from the acute event and subdivided in
cortico-subcortical and subcortical strokes; evaluations were also
performed at 3 months after stroke to monitor changes in brain
reorganization and clinical behavior.
MATERIALS AND METHODS
Participants and Study Protocol
A total of 82 stroke patients were screened at the
Neurorehabilitation Unit of University Hospital of Pisa.
Inclusion criteria were: (1) age ranged between 18 and 80
years; (2) first-ever unilateral ischemic stroke; (3) time from
acute event within 45 days. Exclusion criteria were: (1) TMS
contraindications (cardiac pacemaker, use of drugs targeting
CNS, diagnosis of epilepsy); (2) MMSE<24.
Twenty subjects were excluded for the hemorrhagic nature
of the event and another 20 because they have previously
experienced a cerebrovascular event. Among the 42 remaining
patients, other 12 were excluded because they met our exclusion
criteria.
Therefore, 30 ischemic stroke patients (M/F: 19/11; mean age
± SD: 69.51 ± 13.59 years) were enrolled and divided in two
groups according to lesion site: 15 with cortical-subcortical (CS)
and 15 with subcortical (S) lesion. Finally, 20 of them ended all
the evaluations (M/F: 10/10; 9 with CS and 11 with S lesion; 7
with right lesioned hemisphere and 13 with left lesions). Based
on brain CT images, lesions were defined as “subcortical” if they
involved the deep white matter inferior to the corpus callosum,
including the internal capsule, thalamus and basal ganglia and
spared the cerebral cortex. Otherwise all lesions including also a
cortical involvement were defined a “cortico-subcortical.”
Data about age, gender, affected hemisphere (right or left),
lesion location, time since stroke and drugs used were obtained
from all subjects. Fifteen healthy right-handed control subjects
(M/F: 9/6; mean age ± SD: 33.9 ± 14.75 years), were also
included. They did not present any neurological or other severe
medical diseases. They did not have contraindications for TMS.
Clinical and neurophysiological assessments were performed
at baseline, in a range of 10–45 days (t0), and at 3 months (t1)
after the acute event.
Each patient and healthy subject recruited gave their written
informed consent. This study was authorized by local Ethics
committee of Area Vasta Nord Ovest (CEAVNO) for Clinical
experimentation, Tuscany (Italy).
Transcranial Magnetic Stimulation
TMS was performed using aMagProX100MagOption stimulator
(MagVenture, Farum, Denmark) connected to a figure-eight coil.
During stimulation, the coil was held with the handle pointing
postero-laterally at an angle of 45◦ to midline. Participants
were comfortably seated in a chair with forearms and hand
supinated and supported by a custom built device. The elbow was
positioned in 90◦ flexion. Surface EMG recordings were made
bilaterally from the abductor pollicis brevis muscle (APB). The
position at which the stimulation produced optimal MEP in the
contralateral APB was identified on each side. The raw EMG
signal acquired at 512Hz sampling frequency, was then amplified
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TABLE 1 | Patient characteristics and clinical evaluations at baseline.
Patient Age Gender Lesion Affected t0 BI FMA-UL FMA–UL FMA–UL FMA–UL FMA–UL WMFT WMFT time
site Arm (days) MF PjM P SF Tot score (sec.)
1 54 M CS L 31 5 6 22 22 7 57 6 1451
2 65 M CS L 15 5 5 22 20 2 49 4 1568
3 79 F CS R 23 30 56 24 24 NV 104 65 70
4 85 M CS R 45 0 2 21 24 NV 47 0 1800
5 76 M CS R 26 25 4 20 24 11 59 0 1800
6 80 F CS R 45 5 18 22 24 6 70 19 1050
7 77 F CS L 14 10 4 24 24 6 58 0 1800
8 59 M CS L 19 90 51 24 23 11 109 66 98.21
9 73 F CS L 34 10 45 19 24 9 97 50 120
10 61 F CS R 14 85 62 24 24 7 94 74 52.91
11 54 M S L 22 35 17 23 21 9 70 38 370
12 59 M S R 45 10 8 22 20 NV 50 0 1800
13 78 M S R 19 30 52 24 20 12 108 74 52
14 63 M S L 19 30 19 22 24 12 77 16 897
15 65 M S R 32 35 21 21 23 12 77 29 482
16 22 M S R 21 95 62 24 24 12 122 66 39
17 82 F S L 27 20 48 22 24 12 106 58 104
18 52 M S R 15 100 65 24 24 12 125 67 38
19 73 M S L 11 55 40 24 22 11 97 60 64
20 80 M S L 18 20 9 23 24 11 65 4 1457
General characteristics of each patient: age, gender, lesion location (Cortico-subcortical, CS, or purely subcortical, S), affected arm and number of days between the acute event and
baseline evaluation (T0). Clinical assessment: BI (Barthel Index); FMA -UL (Fugl-Meyer Assessment for upper limb motor function) Total score (Tot) and sub scores of Motor function
(MF), Passive joint motion (PJM), Pain (P), and Sensory function (SF); WMFT (Wolf Motor Function Test) Score and Time.
and band-pass filtered (30–1000Hz) by Neurotravel Win—
Cadwell (Ates Medical Device) using Sierra Wave software. The
off-line analysis was made on a laboratory computer with custom
routines written in Matlab (The MathWorks Inc., Natick, MA,
USA).
Resting Motor Threshold (RMT) and contralateral SP (cSP)
duration parameters were collected from both hemisphere in
stroke patients and from dominant hemisphere in control
subjects. RMT was defined as the intensity needed to elicit a
response with >50 mV amplitude (peak-to-peak) in at least 5
of 10 stimuli. RMT value was defined as 100% if no MEP could
be evoked at maximum stimulator output (MSO) (Takechi et al.,
2014). SP wasmeasured applying a TMS pulse at a suprathreshold
intensity of 120% of RMT when the APB muscle was actively
contracted. The cSP duration was defined between the MEP
onset and the return of continuous EMG-activity to pre-stimulus
levels (van Kuijk et al., 2014). TMS was delivered 100 ms after
starting EMG recording with a 500ms storage sweep so that
pre- and post-stimulus activity could be satisfactorily recorded.
TMS pulses were delivered during voluntary isometric muscle
contraction of approximately 5 s with the instruction to maintain
contraction at least 2 s after the stimulus. The contraction force
was set to 20% of maximal force level with online monitoring.
Five cSP trials for each hemisphere in each patient were
collected and then analyzed after getting the mean value.
Furthermore, background EMG levels were determined with the
root mean square (RMS) amplitude of the EMG activity during
the time period from 100 to 25ms before TMS stimulus delivery.
Clinical Evaluations
Clinical scales to evaluate activities of daily living (Barthel
Index—BI) and upper limb motor function (Fugl-Meyer
Assessment for the upper limb—FMA-UL and Wolf Motor
Function Test—WMFT) were also administered. BI is an
assessment scale divided in 10 items to evaluate patient’s ability
to care for him/herself (Mahoney and Barthel, 1965). FMA is a
feasible, well-designed and widely used scale for global clinical
examination. FMA for the upper limb can be divided in 4 items:
sensory function, pain, passive joint motion and motor function
(Fugl-Meyer et al., 1974; Gladstone et al., 2002). WMFT is a
time-based method to evaluate upper extremity function while
providing insight into joint-specific and total limb movements
(Wolf et al., 2001).
Data Analysis and Statistics
Our sample was characterized by a non-Gaussian distribution
(Shapiro-Wilk’s P > 0.01) then non-parametric statistics was
used. Wilcoxon signed-rank test was used to analyse longitudinal
changes between t0 and t1 in CS and S subgroups. Clinical
and neurophysiological data were compared between the
two stroke subgroups and neurophysiological data were also
compared between the whole stroke group and controls.
Clinical data were also analyzed in other two subgroups
identified by the presence of MEP at t0. The difference in
the same value between t0 and t1 was calculated subtracting
from the t1 value the t0 value (1). Besides, we calculated the
percentage of increase or decrease of time parameters such
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as WMFT time (indicated with %). Outlier rejection was
made using a calculator performing Grubbs’ test. Spearman’s
Correlation Coefficient was used to identify possible correlation
between TMS variables and clinical scores at two different
time points. Furthermore, to assess differences between
study groups (CS and S or MEP±) Mann-Whitney’s U test
was used. Bonferroni correction was applied for multiple
comparisons.
To rule out systematic differences in background EMG over
time or within groups that could impact on SP duration, we also
performed repeated measures ANOVA analysis of RMS values.
IBM SPSS Statistics 20 software for analysis was used.
RESULTS
Clinical Findings
Clinical evaluations were administered at baseline (Table 1)
and at t1 to all patients (Table 2). At baseline, no statistically
TABLE 3 | Neurophysiological parameters: motor evoked potentials and
cortical silent period.
Whole stroke group CS group S group Controls
UH RMT t0 51.6315789 54.4444444 49.1 54.6428571
UH RMT t1 54.15 60 48.3
AH RMT t0 62.5714286 63.8333333 61.625 54.6428571
AH RMT t1 61.3333333 57.5 63.8888889
UH cSP t0 0.14880298 0.1334 0.16035521 0.13915
UH cSP t1 0.14627556 0.17294762 0.1229375
AH cSP t0 0.20652727 0.169275 0.22781429 0.13915
AH cSP t1 0.17679679 0.182405 0.17329167
UH, Unaffected Hemisphere; AH, Affected Hemisphere; RMT, Resting Motor Threshold;
cSP, contralateral Silent Period; CS, cortico-subcortical stroke patients; S, subcortical
stroke patients.
significant differences were observed between two subgroups
except for Barthel Index, in which S patients demonstrated a
significant better score compared with CS patients (P = 0.023)
(Figure 1).
From baseline to t1, significant functional improvement was
evident in BI in CS and S groups (P = 0.008 and P = 0.012,
respectively) (Figure 1), in FMA-UL motor function subscore
(P = 0.012 and P = 0.008, respectively) (Figure 2), in FMA-UL
total score (P = 0.008 and P = 0.005, respectively) (Figure 3).
However, only S group showed a significant improvement in
upper limb fine motility, expressed in WMFT score (P = 0.008)
(Figure 4) and time (P = 0.008) (Figure 5), while improvement
in fine motility scale observed in CS group was marginally
significant [WMFT score (P = 0.027) and time (P = 0.028)
(Figures 4, 5)].
Neurophysiological Data
Motor Evoked Potentials
RMT was recorded from both hemisphere in all stroke patients
and from the dominant side in controls (Table 3). A wide inter-
subject variability in RMT values was evident. In particular,
analysis at t0 did not show a significant difference between the
mean value of RMT in stroke patients and controls (UH P =
0.797; AH P = 0.152). Moreover, at t0 no significant difference
in RMT values was found comparing the two stroke subgroups
(UH P = 0.127; AH P = 0.794) (Figures 6, 7).
Patients in which MEPs could not be elicited (and RMT was
defined as 100% of MSO) were: three at t0 for cortico-subcortical
group and two at t1; for subcortical group two patients at t0 and
one at t1.
Silent Period
As regards Silent Period (SP) recordings, cSP was collected from
both hemispheres in all stroke subjects and from dominant
hemisphere in controls (Table 3).
FIGURE 1 | Barthel Index (at baseline and at 3 months). Barthel Index score at baseline and at t1. The blue histogram corresponds to cortico-subcortical
lesioned patients, the pink one to subcortical stroke patients. BI, Barthel Index; CS, cortico-subcortical stroke patients; S, subcortical stroke patients. *P < 0.05.
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FIGURE 2 | Fugl-Meyer Assessment for the upper limb—motor function (at baseline and at 3 months). Fugl-Meyer Assessment for the upper limb—Motor
function subscore values at baseline and at t1. The blue histogram corresponds to cortico-subcortical lesioned patients, the pink one to subcortical stroke patients.
FMA-UL, Fugl-Meyer Assessment for the upper limb; FM, motor function subscore; CS, cortico-subcortical stroke patients; S, subcortical stroke patients. *P < 0.05.
FIGURE 3 | Fugl-Meyer Assessment for the upper limb—total score (at baseline and at 3 months). Fugl-Meyer Assessment for the upper limb—total score
values at baseline and at t1. The blue histogram corresponds to cortico-subcortical lesioned patients, the pink one to subcortical stroke patients. FMA-UL, Fugl-Meyer
Assessment for the upper limb; CS, cortico-subcortical stroke patients; S, subcortical stroke patients. *P < 0.05.
At baseline no significant difference was found by comparing
the whole stroke group with controls (P = 0.710) (Figure 8).
From t0 to t1 a statistically significant reduction in UH cSP in
S patients was found (P = 0.049) (Figure 9).
At t0 no statistically significant difference was found in cSP
recorded from AH between the two stroke subgroups (P =
0.571). AH cSP decreased at t1 in S group, but this trend was not
statistically significant (P = 0.463) (Figure 10).
RMS analysis over time and within groups showed that the
differences in background EMG levels did not impact on the
interpretation of silent period data in our sample.
Correlations between Clinical and
Neurophysiological Parameters
The relationship between clinical and neurophysiological
parameters was also explored. In particular we analyzed
time-related parameters’ changes from t0 to t1.
S group showed a negative correlation between 1cSP on UH
and 1WMFT score (P = 0.049; Spearman’s Rho = −0.633)
(Figure 11) and a positive correlation with %WMFT time (P
= 0.002; Spearman’s Rho = 0.851) (Figure 12). It means that
the reduction of cSP on UH was paralleled by an increase
on WMFT score and a decrease of WMFT time. Correlations
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FIGURE 4 | Wolf Motor Function Test score (at baseline and at 3 months). Wolf Motor Function Test Score at baseline and at t1. The blue histogram
corresponds to cortico-subcortical lesioned patients, the pink one to subcortical stroke patients. WMFT, Wolf Motor Function Test; CS, cortico-subcortical stroke
patients; S, subcortical stroke patients. *P < 0.05.
FIGURE 5 | Wolf Motor Function Test time (at baseline and at 3 months). Wolf Motor Function Test time at baseline and at t1. The blue histogram corresponds
to cortico-subcortical lesioned patients, the pink one to subcortical stroke patients. WMFT, Wolf Motor Function Test; CS, cortico-subcortical stroke patients; S,
subcortical stroke patients.
analysis in S group showed that 1cSP on AH negatively related
with FMA-UL—passive motility subscore at t0 (P = 0.044;
Spearman’s Rho=−0.819), FMA-UL—motor function subscore
at t0 (P = 0.032; Spearman’s Rho = −0.675), FMA-UL—total
score at t0 (P = 0.034 Spearman’s Rho = −0.671), WMFT
score at t0 (P = 0.009; Spearman’s Rho = −0.772). Moreover,
the reduction of AH cSP from t0 to t1 (1cSP) in S patients,
reflected a higher score of BI (P = 0.048; Spearman’s Rho
= −0.637), FMA-UL—motor function subscore (P = 0.012;
Spearman’s Rho = −0.755), FMA-UL—total score (P = 0.010;
Spearman’s Rho= −0.764),WMFT score (P= 0.012; Spearman’s
Rho = −0.751), at t1. In the same stroke subgroup 1cSP
on AH positively related with WMFT time at t0 (P = 0.007;
Spearman’s Rho = 0.784) and at t1 (P = 0.018; Spearman’s
Rho = 0.723) and negatively related with 1WMFT time (P
= 0.039; Spearman’s Rho = −0.657): the reduction of cSP
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FIGURE 6 | Motor evoked potentials: Resting Motor Threshold in the unaffected hemisphere. The figure represents Resting Motor Threshold (RMT) for
stimulation of unaffected hemisphere at t0 and t1. RMT value was described as 100% if no MEP could be evoked at maximum stimulator output. CS,
cortico-subcortical stroke patients; S, subcortical stroke patients.
FIGURE 7 | Motor evoked potentials: Resting Motor Threshold in the affected hemisphere. The figure represents Resting Motor Threshold (RMT) for
stimulation of affected hemisphere at t0 and t1. RMT value was described as 100% if no MEP could be evoked at maximum stimulator output. CS, cortico-subcortical
stroke patients; S, subcortical stroke patients.
values on AH corresponds to shorter times of execution in
WMFT.
Clinical Scales in Groups Divided for MEP Presence
Even if both groups presented a time-related improvement, the
group with MEP at t0 presented higher fine hand mobility
values than the group without MEP at t0, assessed with WMFTs
(Figure 13) and WMFT t both at baseline (P = 0.004; P = 0.006)
and at t1 (P= 0.012; P= 0.013). Improvements in the two groups
(measures by1) were not statistically different.
DISCUSSION
Our main finding is that the group of patients with subcortical
stroke evaluated in this study presented a reduction in
contralateral Silent Period (SP) duration in the unaffected
hemisphere and this trend is related to clinical improvement 3
months after the acute event. It is well known that the SP can
be divided in two parts: an early part principally due to spinal
mechanisms and the late part due to inhibition mechanisms
of the motor cortex (Chen et al., 1999) mediated through type
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B-GABAergic interneurons receptors (Di Pino et al., 2014).
Literature reported that SP is prolonged in the acute phase after
an injury (Liepert et al., 2000b) and it normalizes with the
clinical improvement (Classen et al., 1997). In this study we
observed a no significant reduction of cSP duration in the AH
at 3 months, but this trend (1 cSP) correlated with functional
recovery. Otherwise, the reduction of unaffected intracortical
inhibition in S patients may play an important role in effective
motor recovery at 3 months.
Changes in cortical activity after stroke have already been
investigated in recent literature. Previous studies (Liepert et al.,
2000a; Manganotti et al., 2002; Swayne et al., 2008) reported that
RMT values were higher on the AH than on the UH. However,
FIGURE 8 | Cortical Silent Period in the whole stroke group and in
controls. The figure represents contralateral Silent Period recorded by
unaffected hemisphere stimulation of whole stroke group and dominant
hemisphere in controls. Silent Period were collected at t0 (1) and t1 (2) in
stroke patients, while control subjects were evaluated only once (therefore
column 1 and 2 are equal for this group).
the baseline excitability of the AH seems to be less relevant:
Swayne et al. (2008) showed a poor correlation between AH
neurophysiological features and clinical behavior at 6 months
after stroke. The main hypothesis was that the reorganization
of alternative cortical networks was more relevant for motor
recovery than the function of the original corticospinal tract
spared by the ischemic lesions. The role of UH motor cortex
in post-lesional recovery is still debated (Takechi et al., 2014).
It was supposed that unaffected hemisphere facilitates control
of recovered motor function by operating at a higher-order
processing level involved in selection, preparation, temporal or
spatial organization of movement (Gerloff et al., 2006). Bütefisch
et al. (2003) compared stroke patients with good recovery of hand
function and controls to determine changes in the inhibitory and
excitatory activity in UH motor cortex in stroke patients. They
found that in patients’ contralesional motor cortex the balance of
excitatory and inhibitory activity was shifted toward an increase
of excitatory activity; they postulated that in stroke subjects this
issuemay be relevant for reorganizational processes andmay play
a role in the functional recovery of patients.
The present study showed substantial stability of RMT values
in UH in S group, whereas CS patients showed a no significant
increase in RMT value over time. In literature, Manganotti
et al. (2002) reported a decrease of RMT in UH detectable
in a very early phase after the acute event (5–7 days after
stroke) and a trend toward the normalization in patients who
experimented a good recovery. Contrarily, the persistence of
abnormal excitability in UH was associated with a poor motor
recovery. Our data highlighted a substantial stability of UH
excitability within 3 months in subcortical patients. The different
timing of neurophysiological evaluations may have contributed
to mask the effect due to a wider variability. In fact, we described
the UH excitability trend in a window between 10 and 45 days
after stroke, whereas Manganotti et al. (2002) chose an earlier
FIGURE 9 | Cortical Silent Period in the unaffected hemisphere. The figure represents contralateral Silent Period recorded by unaffected hemisphere stimulation
at t0 and t1 in cortico-subcortical and subcortical stroke patients. CS, cortico-subcortical stroke patients; S, subcortical stroke patients. *P < 0.05.
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FIGURE 10 | Cortical Silent Period in the affected hemisphere. The figure represents contralateral Silent Period recorded by affected hemisphere stimulation at
t0 and t1 in cortico-subcortical and subcortical stroke patients. CS, cortico-subcortical stroke patients; S, subcortical stroke patients.
FIGURE 11 | Correlations between clinical and neurophysiological parameters. Correlation between 1cSP on unaffected hemisphere and 1WMFT score in
subcortical stroke subgroup. cSP, contralateral Silent Period; WMFT, Wolf Motor Function Test; 1, The difference between t0 and t1 in the same value, calculated
subtracting as t1–t0.
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FIGURE 12 | Correlations between clinical and neurophysiological parameters. Correlation between 1cSP on UH and %WMFT time in subcortical stroke
subgroup. cSP, contralateral Silent Period; WMFT, Wolf Motor Function Test; UH, unaffected hemisphere; %, the percentage of increase or decrease of WMFT time.
FIGURE 13 | Wolf Motor Function Test Score in groups divided for MEP
presence. Fine hand mobility improvement (assessed with WMFT) in groups
divided based on MEP presence (MEP +, represented in blue) or absence
(MEP –, represented in red) at t0.
timing. Swayne et al. (2008) affirmed that the earliest period
after stroke is characterized by a wide variability in cortical
reorganization and this could account for the different results
of our work. Probably, a larger and more homogeneous dataset
would help us to resolve this issue and establish a proper timing
to characterize neurophysiological changes and correlations with
clinical outcome.
Moreover, as already described in literature the presence of
MEP in the earliest phase after stroke has a positive predictive
value for motor recovery (Stinear et al., 2014). TMS responses
were not collected before the first 10 days, so MEP presence at
baseline cannot be considered as a predictive factor in our study.
However, it emerged that patients with MEP in the affected side
at t0 had a better basal clinical score, but not a greater degree of
motor recovery.
Regarding the meaning of post-lesional changes observed in
the unaffected motor cortex, Shimizu et al. (2002) interpreted the
post-lesional cortical changes in the contralateral side as “motor
cortex disinhibition,” i.e., a consequent manifestation of the
lesion itself. Our data indicate that changes in UH motor cortex
could be well described with the modifications detectable with
cSP. Moreover, in S patients the cSP demonstrated a clear-cut
correlation with clinical outcome.
In conclusion, our analysis proved that cSP is a valid
parameter to characterize cortical reorganization patterns in
subacute stroke subjects. Furthermore, this measure significantly
correlated with motor function in S patients and provided useful
information about motor recovery within 3 months.
Limitations of the Study
There are some limitations to consider. First of all, small sample
size and variability of the clinical features of patients recruited
suggest that results need to be confirmed in further studies, which
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will include larger samples. Furthermore, control group’s mean
age was lower than that of stroke patients and it could have
influenced results.
As regards baseline evaluations, the first clinical and
neurophysiological measures were made between 10 and 45
days post-stroke. No information about the earliest phase were
collected. Moreover, changes in both motor performance and
neurophysiological measures may occur between 2 and 6 weeks
after stroke.
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